As Citigroup (C) Market Value Rose, Tokio Marine Asset Management Co LTD Has Lowered Holding; As Cvs Health (CVS) Share Value Declined, University Of Notre Dame Du Lac Trimmed Position

December 7, 2017 - By Peter Erickson

Tokio Marine Asset Management Co Ltd decreased its stake in Citigroup Inc (C) by 28.4% based on its latest 2017Q2 regulatory filing with the SEC. Tokio Marine Asset Management Co Ltd sold 11,600 shares as the company’s stock rose 1.55% with the market. The institutional investor held 29,252 shares of the major banks company at the end of 2017Q2, valued at $1.96 million, down from 40,852 at the end of the previous reported quarter. Tokio Marine Asset Management Co Ltd who had been investing in Citigroup Inc for a number of months, seems to be less bullish one the $199.46 billion market cap company. The stock decreased 1.44% or $1.1 during the last trading session, reaching $75.44. About 16.61 million shares traded or 8.08% up from the average. Citigroup Inc. (NYSE:C) has risen 35.60% since December 7, 2016 and is uptrending. It has outperformed by 18.90% the S&P500.

University Of Notre Dame Du Lac decreased its stake in Cvs Health Corp (CVS) by 31.03% based on its latest 2017Q2 regulatory filing with the SEC. University Of Notre Dame Du Lac sold 23,823 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 52,954 shares of the medical and nursing services company at the end of 2017Q2, valued at $4.26M, down from 76,777 at the end of the previous reported quarter. University Of Notre Dame Du Lac who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $72.31B market cap company. The stock increased 0.52% or $0.37 during the last trading session, reaching $71.38. About 12.37M shares traded or 42.44% up from the average. CVS Health Corporation (NYSE:CVS) has declined 24.40% since December 7, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.




More notable recent Citigroup Inc. (NYSE:C) news were published by: Reuters.com which released: “Citigroup sees ‘high teens’ percentage decline in fourth-quarter markets revenue” on December 06, 2017, also Investorplace.com with their article: “Pick Up Citigroup Inc Stock Before the Breakout” published on November 30, 2017, Reuters.com published: “Citigroup expects ‘high teens’ percentage fall in fourth-quarter markets revenue” on December 06, 2017. More interesting news about Citigroup Inc. (NYSE:C) were released by: Seekingalpha.com and their article: “Citi Warrants – An Unusual Case” published on December 04, 2017 as well as Investorplace.com‘s news article titled: “What You Have to Know About Citigroup Inc” with publication date: November 29, 2017.

Analysts await Citigroup Inc. (NYSE:C) to report earnings on January, 17. They expect $1.27 EPS, up 11.40% or $0.13 from last year’s $1.14 per share. C’s profit will be $3.36B for 14.85 P/E if the $1.27 EPS becomes a reality. After $1.42 actual EPS reported by Citigroup Inc. for the previous quarter, Wall Street now forecasts -10.56% negative EPS growth.

Tokio Marine Asset Management Co Ltd, which manages about $696.04 million US Long portfolio, upped its stake in Signature Bk New York N Y (NASDAQ:SBNY) by 25,900 shares to 62,100 shares, valued at $8.91M in 2017Q2, according to the filing. It also increased its holding in Ball Corp (NYSE:BLL) by 10,140 shares in the quarter, for a total of 22,391 shares, and has risen its stake in Csx Corp (NYSE:CSX).

Among 37 analysts covering Citigroup Inc. (NYSE:C), 19 have Buy rating, 3 Sell and 15 Hold. Therefore 51% are positive. Citigroup Inc. had 103 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by BMO Capital Markets on Monday, July 31 to “Market Perform”. The company was upgraded on Tuesday, September 12 by Societe Generale. BMO Capital Markets maintained the shares of C in report on Friday, October 6 with “Hold” rating. The firm has “Buy” rating by SunTrust given on Monday, August 24. Morgan Stanley upgraded Citigroup Inc. (NYSE:C) on Monday, November 14 to “Overweight” rating. The firm has “Buy” rating given on Tuesday, September 5 by Vertical Group. The stock of Citigroup Inc. (NYSE:C) earned “Buy” rating by BMO Capital Markets on Friday, July 14. The firm has “Hold” rating by Deutsche Bank given on Tuesday, January 26. The company was upgraded on Tuesday, August 25 by Zacks. Credit Suisse upgraded the stock to “Outperform” rating in Monday, September 28 report.

Investors sentiment is 1.1 in 2017 Q2. Its the same as in 2017Q1. It is without change, as 67 investors sold C shares while 443 reduced holdings. only 124 funds opened positions while 435 raised stakes. 2.03 billion shares or 1.74% more from 2.00 billion shares in 2017Q1 were reported. Kbc Nv holds 0.44% or 675,853 shares in its portfolio. Fil reported 13.27M shares. Beck Capital Mgmt Limited Liability Company has invested 0.55% of its portfolio in Citigroup Inc. (NYSE:C). Elm Ridge Mgmt Limited Com invested in 4.43% or 201,529 shares. Sterling Capital Mgmt Ltd reported 9,618 shares. Cibc Mkts invested in 519,061 shares or 0.37% of the stock. Pitcairn Co holds 13,200 shares or 0.11% of its portfolio. Nj State Employees Deferred Compensation Plan stated it has 0.1% in Citigroup Inc. (NYSE:C). Discovery Mngmt Llc Ct owns 973,600 shares. Bsw Wealth reported 0.24% of its portfolio in Citigroup Inc. (NYSE:C). Joel Isaacson Llc has invested 0.11% in Citigroup Inc. (NYSE:C). Connable Office Inc holds 89,002 shares or 1.3% of its portfolio. Sterneck Capital Mgmt Ltd Liability holds 38,625 shares. Polar Cap Limited Liability Partnership holds 1.4% or 1.55 million shares in its portfolio. Rathbone Brothers Public Ltd Co holds 0.56% in Citigroup Inc. (NYSE:C) or 189,304 shares.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS Health – Attractive Long-Term Income Play” on November 24, 2017, also Seekingalpha.com with their article: “The CVS-Aetna Merger: Under The Shadow Of Amazon?” published on December 05, 2017, Seekingalpha.com published: “CVS Healthcare Is No Longer A Dividend Growth Company” on December 06, 2017. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Cnbc.com and their article: “Jefferies slashes its CVS Health price forecast on Amazon competition risk” published on November 07, 2017 as well as Fool.com‘s news article titled: “Better Buy: CVS Health Corporation vs. Wal-Mart” with publication date: November 16, 2017.

Since June 12, 2017, it had 0 buys, and 1 insider sale for $18.44 million activity.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 earnings per share, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92 billion for 9.39 P/E if the $1.90 EPS becomes a reality. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Among 25 analysts covering CVS Health (NYSE:CVS), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. CVS Health had 58 analyst reports since July 22, 2015 according to SRatingsIntel. As per Tuesday, November 7, the company rating was maintained by Loop Capital. The firm earned “Buy” rating on Thursday, May 12 by Jefferies. The firm has “Buy” rating given on Wednesday, August 19 by Evercore. Oppenheimer maintained the stock with “Outperform” rating in Monday, November 2 report. On Monday, June 20 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. Jefferies maintained the shares of CVS in report on Friday, June 9 with “Hold” rating. The firm has “Buy” rating given on Monday, August 24 by Vetr. Jefferies maintained the stock with “Hold” rating in Wednesday, August 16 report. The stock has “Buy” rating by Needham on Monday, December 4. Jefferies maintained CVS Health Corporation (NYSE:CVS) on Tuesday, November 7 with “Hold” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.